Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Boom in use Medical Cannabis in Australia ! LABS is there :)
View:
Post by 1hot-techwoman on Apr 10, 2024 7:18am

Boom in use Medical Cannabis in Australia ! LABS is there :)

https://www.msn.com/en-ca/video/webcontent/boom-in-use-of-medical-cannabis-in-australia-landline-abc-australia/vi-4PeFKRqWvoc9YQ?vid=UsrBpqQl_Tg&provider=yt&ocid=hpmsn&cvid=17d8c09b47cd4e6f9c19eff21a73a47f&ei=44
Comment by subaru1i on Apr 10, 2024 8:17am
...and LABS has ALL the certifications to be a CDMO for anyone wanting to enter that market for MEDICAL. 
Comment by mdjbrown on Apr 10, 2024 10:09am
Agree 100% s1i Medipharm appears to feel they may have a regulatory edge in Australia in the future “and Keith mentioned the Australia opportunity where a number of manufacturers were no longer able to provide GMP products for the market. And our activity level of many people coming to us, Australia and Brazil and other places where we -- as the rules get stricter, fewer companies can meet the ...more  
Comment by subaru1 on Apr 10, 2024 1:29pm
mdjbrown, thank you very much for sharing the script.
Comment by mdjbrown on Apr 10, 2024 1:50pm
You are very welcome s1.  Things are finally looking up for us longs!
Comment by subaru1 on Apr 10, 2024 2:02pm
It sounds like 2024 might finally be the year that many of us are waiting for. We might hit the valuation of $0,15 by year end as per Labs management commentary, sounds good to me.
Comment by okgonow on Apr 10, 2024 2:27pm
or with a bit of more luck there will be some healthy overexuberance when it comes to MPL and pople wanting in and the price goes a few multiples of the $.15 you mentioned. you are paying for forward possibilities and income
Comment by allibabba on Apr 10, 2024 3:12pm
Lol, so you think that if they become profitable they'll barely be worth more than their cash and assets.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities